Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
-
br Experimental Procedures br Author Contributions br
2018-10-20
Experimental Procedures Author Contributions Acknowledgments Introduction Duchenne muscular dystrophy (DMD) is a severe muscular degenerative disease caused by loss-of-function mutations in the dystrophin gene located on the X chromosome. The dystrophin gene consists of 79 exons, and dis
-
TAU fragments carry an apoptosis
2018-10-20
TAU fragments carry an apoptosis-inducing activity, which is further potentiated when tnf alpha inhibitors are exposed to TAU fragments carrying the N279K mutation (Fasulo et al., 2005). In addition, overexpression of full-length TAU carrying the N279K or the V337M mutation resulted in induction of
-
br Results and Discussion br Experimental Procedures br
2018-10-20
Results and Discussion Experimental Procedures Acknowledgments We would like to thank V. Makatounakis and G. Vretzos for technical assistance, as well as I. Stratidaki for her contribution in miRNA sequencing profiling by the Ion Torrent platform (IMBB). We also thank Prof. D. Kardasis and
-
Hello world!
2018-07-29
15829 records 1056/1056 page Previous First page 上5页 1056